The effect of the molecular mechanism of G protein-coupled receptor activation on the process of signal transduction

European Journal of Pharmacology

Volumn 335, Issue 1, 1997, Pages 73-87

  Pardo, Leonardo ^a   Campillo, Mercedes ^a   Giraldo, Jesús ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Conformational states, multiple; Inverse agonist; Ligand efficacy; Signal transduction; Thermodynamic model

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; ENERGY TRANSFER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THERMODYNAMICS;

COMPUTER SIMULATION; GTP-BINDING PROTEINS; MODELS, CHEMICAL; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; THERMODYNAMICS;

EID: 0030822479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01170-9     Document Type: Article

References (28)

1. Black J.W., Leff P. Operational models of pharmacological agonism. Proc. R. Soc. Lond. B. 220:1983;141-162.
2. Black J.W., Shankely N.P. Interpretation of agonist affinity estimations: The question of distributed receptor states. Proc. R. Soc. Lond. B. 240:1990;503-518.
3. Bond R.A., Leff P., Johnson T.D., Milano C.A., Rockman H.A., Mcminn T.R., Apparsundaram S., Hyek M.F., Kenakin T.P., Allen L.F., Lefkowitz R.J. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta(2)-adrenoceptor. Nature. 374:1995;272-276.
4. Bruns R.F. Conformational induction versus conformational selection: Evidence from allosteric enhancers. Trends Pharmacol. Sci. 17:1996;189.
5. Burgen A.S.V. Conformational changes and drug action. Fed. Proc. 40:1981;2723-2728.
6. Costa T., Ogino Y., Munson P.J., Onaran O., Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41:1992;549-560.
7. DeLean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:1980;7108-7117.
8. 2 adrenergic receptor. evidence for ligand-specific conformational changes. J. Biol. Chem. 270:1995;28268-28275.
9. Karlin A. On the application of 'a Plausible Model' of allosteric proteins to the receptor for acetylcholine. J. Theor. Biol. 16:1967;306-320.
10. Katz B., Thesleff S. A study of the 'desensitization' produced by acetylcholine at the motor end-plate. J. Physiol. Lond. 138:1957;63-80.
11. Kenakin T. Agonist-receptor efficacy I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16:1995;188-192.
12. Kenakin T. Receptor conformational induction versus selection: All part of the same energy landscape. Trends Pharmacol. Sci. 17:1996;190-191.
13. 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267:1992;1430-1433.
14. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 16:1995;89-97.
15. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:1993;303-307.
16. Lewis J.W., Kliger D.S. Photointermediates of visual pigments. J. Bioenerg. Biomembr. 24:1992;201-210.
17. Mackay D. Agonist potency and apparent affinity: Interpretation using classical and steady-state ternary-complex models. Trends Pharmacol. Sci. 11:1990;17-22.
18. 2-adrenergic receptor. Science. 264:1994;582-586.
19. Morgan P. Agonist action revisited. Trends Pharmacol. Sci. 14:1993;421-423.
20. Neer E.J. Heterotrimeric G proteins: Organizers of transmembrane signals. Cell. 80:1995;249-257.
21. 2-adrenergic receptor. J. Biol. Chem. 268:1993;16483-16487.
22. Rhee A.M.v., Jacobson K.A. Molecular architecture of G protein-coupled receptors. Drug Dev. Res. 37:1996;1-38.
23. 2-adrenergic receptor. J. Biol. Chem. 268:1993;4625-4636.
24. 1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J. 15:1996;3566-3578.
25. Thron C.D. On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol. 9:1973;1-9.
26. Weiss J.M., Morgan P.H., Lutz M.W., Kenakin T.P. The cubic ternary complex receptor-occupancy model I. Model description. J. Theor. Biol. 178:1996;151-167.
27. Wess J., Nanavati S., Vogel Z., Maggio R. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 12:1993;331-338.
28. 2 receptor: A mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J. Med. Chem. 36:1993;934-938.